203 related articles for article (PubMed ID: 2730233)
1. Muscarinic supersensitivity and subsensitivity induced by chronic treatment with atropine and diisopropylfluorophosphate in rat submaxillary glands.
Ukai Y; Taniguchi N; Ishima T; Kimura K
Arch Int Pharmacodyn Ther; 1989; 297():148-57. PubMed ID: 2730233
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
3. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
4. [Effects of diisopropylfluorophosphate, paraoxon and dichlophos on [3H] quinuclidinyl benzylate binding to the rat striatum synaptic membranes].
Golovko AI; Sofronov GA; Nikolaeva TV; Kliuntina TV
Biull Eksp Biol Med; 1992 Sep; 114(9):290-1. PubMed ID: 1477363
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
6. [Effects of propiverine hydrochloride (propiverine) on the muscarinic receptor binding affinity in guinea pig tissues and on salivation in conscious dogs].
Nagao M; Kaneko S; Hirota T; Isogai M; Shimizu H
Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):157-66. PubMed ID: 10347840
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
8. Chronic anethole trithione treatment enhances the salivary secretion and increases the muscarinic acetylcholine receptors in the rat submaxillary gland.
Ukai Y; Taniguchi N; Takeshita K; Kimura K; Enomoto H
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):206-12. PubMed ID: 6508432
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of phosphatidylinositol turnover and cyclic nucleotide accumulation by chronic anethole trithione treatment in rat submaxillary glands.
Ukai Y; Taniguchi N; Yamazaki A; Kimura K
J Pharm Pharmacol; 1989 Apr; 41(4):247-52. PubMed ID: 2568464
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic stimulation of submucosal glands in swine trachea.
Yang CM; Farley JM; Dwyer TM
J Appl Physiol (1985); 1988 Jan; 64(1):200-9. PubMed ID: 3356638
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
Schallert T; Overstreet DH; Yamamura HI
Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation.
Levy A; Zohar J; Belmaker RH
Neuropharmacology; 1982 Nov; 21(11):1199-201. PubMed ID: 7177345
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
Dunlap J; Brown JH
Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
[TBL] [Abstract][Full Text] [Related]
18. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685
[TBL] [Abstract][Full Text] [Related]
19. L-alphacetylmethadol (LAAM) effects on cardiac muscarinic receptors.
Langley AE
Arch Int Pharmacodyn Ther; 1989; 300():140-8. PubMed ID: 2619421
[TBL] [Abstract][Full Text] [Related]
20. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
